Appendix cancer differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
(97 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Appendix_cancer]] | |||
{{CMG}}; {{AE}} {{Soroush}} | {{CMG}}; {{AE}} {{Soroush}} | ||
==Overview== | ==Overview== | ||
Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs. | [[Vermiform appendix|Appendix]] [[cancer]] must be [[Appendix cancer differential diagnosis|differentiated]] from [[Benign|benign appendix lesions]] ([[mucocele]], [[Appendicitis|acute appendicitis]]), [[Colorectal cancer|colorectal cancers]], [[Ovarian cancer|adenexal masses]] ([[Ovarian cancer|ovarian tumors]]), and [[Neuroendocrine tumors|carcinoid tumors of the other organs]]. | ||
==Differentiating appendix cancer from other Diseases== | ==Differentiating appendix cancer from other Diseases== | ||
*Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs. | *[[Vermiform appendix|Appendix]] [[cancer]] must be [[Appendix cancer differential diagnosis|differentiated]] from [[Benign|benign appendix lesions]] ([[mucocele]], [[Appendicitis|acute appendicitis]]), [[Colorectal cancer|colorectal cancers]], [[Ovarian cancer|adenexal masses]] ([[Ovarian cancer|ovarian tumors]]), and [[Neuroendocrine tumors|carcinoid tumors of the other organs]]. | ||
*As appendix cancer manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. | *As [[appendix cancer]] manifests in a variety of [[clinical]] forms, differentiation must be established in accordance with the particular subtype. | ||
:*Carcinoid tumors must be differentiated from other diseases that | :*[[Carcinoid Tumor|Carcinoid tumors]] must be differentiated from other diseases that cause [[carcinoid syndrome]] sign and symptoms such as [[palpitation]], [[Flushing|facial flushing]], and [[diarrhea]]. | ||
:*In contrast, | :*In contrast, [[adenocarcinoma]]<nowiki/>s and cystadenocarcinomas must be differentiated from other diseases that cause [[Appendicitis|acute appendicitis]] or present with [[pseudomyxoma peritonei]], such as [[Colorectal cancer|colorectal cancers]] and [[Appendix cancer echocardiography and ultrasound|appendix mucoceles]]. | ||
<small> | |||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
Line 25: | Line 25: | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings | ||
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo- | ||
pathology | |||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain''' | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain''' | ||
Line 49: | Line 50: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other diagnostic studies and imaging modalities | sounography | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | |||
diagnostic | |||
studies | |||
and | |||
imaging | |||
modalities | |||
|- | |- | ||
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix cancer | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix cancer | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Adenocarcinoma<small><sup>1</sup></small> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Adenocarcinoma|Adeno-]] | ||
[[Adenocarcinoma|carcinoma]]<small><sup>1</sup></small> | |||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | -/+ | | style="background: #F5F5F5; padding: 5px;" | -/+ | ||
| style="background: #F5F5F5; padding: 5px;" | <math>\downarrow</math> | | style="background: #F5F5F5; padding: 5px;" | <math>\downarrow</math> | ||
| rowspan="1" style="background: #F5F5F5; padding: 5px;" | | | rowspan="1" style="background: #F5F5F5; padding: 5px;" | | ||
* '''Generally | * '''Generally [[Asymptomatic|asympto-<br>matic]]''' | ||
* Appendicitis symptoms | * [[Appendicitis]] [[Symptom|symptoms]] | ||
* [[Nausea and vomiting|Nausea & vomiting]],[[ | * [[Nausea and vomiting|Nausea<br>&<br>vomiting]],<br>decreased<br>[[appetite]] | ||
* No gas or stool pass (intestinal obstruction) | * No gas<br>or<br>stool pass<br>([[Bowel obstruction|intestinal<br>obstruction]]) | ||
* Bone pain (bone metastasis) | * [[Bone pain]]<br>(bone<br>[[Metastasis|metastasis)]] | ||
* Bloating (ascites) | * [[Bloating]]<br>([[ascites]]) | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Ascites]] | * [[Ascites]] | ||
* Shifting dullness | * [[Shifting dullness]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* CEA | * [[CEA]] | ||
* CA 19-9 | * [[CA 19-9]] | ||
* | * | ||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" | | | rowspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
* Soft tissue thickening | * Soft<br>tissue<br>thickening | ||
* Wall irregularity | * Wall<br> irregularity | ||
* Presence of | * Presence<br>of<br> [[Pseudomyxoma peritonei|pseudo-<br>myxoma<br>peritonei]] | ||
* Calcification | * [[Calcification]] | ||
* Internal septations | * Internal<br>septations | ||
* | * Peri<br>appendiceal<br>fat<br>stranding<br>and<br>intra-<br>peritoneal<br>free fluid<br> which is a<br> nonspecific<br> finding | ||
* Cystic lesion | * Cystic<br> lesion | ||
* | * | ||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" | | | rowspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
* Diffusion weighted MRI has been shown to be the modality of choice for peritoneal | * Diffusion<br>weighted<br>[[Magnetic resonance imaging|MRI]]<br>has<br>been<br>shown to<br>be<br>the<br>modality<br>of choice<br>for<br>''[[Peritoneal carcinomatosis|peritoneal<br>carcino-<br>matosis]]'' | ||
* Increased fluid signal on T2 weighted sequence | * Increased<br>fluid<br>signal on<br>T2 weighted sequence | ||
* Soft tissue mass in the [[appendix]] | * Soft<br> tissue<br> mass in<br> the<br>[[appendix]] | ||
* Invasion to other structures | * Invasion to<br>the other<br>structures | ||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" | | | rowspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
* Dilated appendix | * Dilated<br>appendix | ||
* | * Peri-<br>appendiceal<br> fluid<br> collection | ||
* Distinct appendix wall layers | * Distinct<br> appendix<br> wall<br> layers | ||
| style="background: #F5F5F5; padding: 5px;" |[[Positron emission tomography]] (PET) | | style="background: #F5F5F5; padding: 5px;" |[[Positron emission tomography|Positron<br>emission<br>tomography]]<br>(PET) | ||
| style="background: #F5F5F5; padding: 5px;" |'''Gross pathology''': | | style="background: #F5F5F5; padding: 5px;" |'''Gross<br>[[pathology]]''': | ||
* Gray/yellow color | * Gray/yellow<br>color | ||
* Cystic structures with angiolymphatic invasion | * Cystic<br>structures<br>with<br>angiolymphatic<br>invasion | ||
* Appendix might be buried within the mass | * [[Vermiform appendix|Appendix]]<br>might be<br>buried<br>within<br>the mass | ||
'''Microscopic pathology:''' | '''Microscopic<br>pathology:''' | ||
* Intestinal, mucinous or signet ring cell types | * Intestinal,<br>mucinous<br>or<br>[[Signet ring cell carcinoma|signet ring<br>cell]] types | ||
* Coexisting acute appendicitis is common | * Coexisting<br>[[Appendicitis|acute<br>appendicitis]]<br>is common | ||
'''IHC | '''[[Immunohistochemistry|IHC]]:''' | ||
* MUC 2 | * MUC 2 | ||
* '''MUC5AC''' | * '''MUC5AC''' | ||
Line 110: | Line 122: | ||
* CK 20 | * CK 20 | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Carcinoid tumor<sup>2</sup> | | style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Carcinoid Tumor|Carcinoid]] | ||
[[Carcinoid Tumor|tumor]]<sup>2</sup> | |||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math> | | style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math> | ||
| rowspan="1" style="background: #F5F5F5; padding: 5px;" | | | rowspan="1" style="background: #F5F5F5; padding: 5px;" | | ||
* '''Generally | * '''Generally [[Asymptomatic|asympto-<br>matic]]''' | ||
* Flushing | * [[Flushing]] | ||
* Palpitation | * [[Palpitation]] | ||
* Dyspnea | * [[Dyspnea]] | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* TR | * [[Tricuspid regurgitation|TR]]<br>[[Heart murmur|murmur]] | ||
* Wheezing | * [[Wheeze|Wheezing]] | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Ki67:<br>a reliable<br>marker of<br>cell<br>proliferation | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Somatostatin]] [[scintigraphy]] with 111-indium-octreotide | * [[Somatostatin]]<br>[[scintigraphy]]<br>with<br> 111-indium-<br>octreotide | ||
* [[Bone]] [[scintigraphy]] with 99mTc-methylene diphosphonate (99mTcMDP) | * [[Bone]]<br>[[scintigraphy]]<br> with<br> 99mTc-<br>methylene<br> diphosphonate<br>(99mTcMDP) | ||
* | * Positron<br>emission<br>tomography<br>(PET) | ||
| style="background: #F5F5F5; padding: 5px;" |'''Gross pathology''': | | style="background: #F5F5F5; padding: 5px;" |'''Gross<br>[[pathology]]''': | ||
* | * [[Prevalence|Prevalent]]<br>at the<br>tip of<br>[[Vermiform appendix|appendix]] | ||
* Generally<br>less than<br>1 cm | |||
* Gray or <br>yellow | |||
* Well-<br>demarcated<br>firm | |||
* Intramural<br>nodules<br>that may<br>narrow or<br>obliterate<br>appendiceal<br> lumen | |||
* Proximal<br>tumors<br>may cause<br>obstruction<br>and<br>appendicitis | |||
'''Microscopic pathology:''' | '''Microscopic<br>pathology:''' | ||
*Insular growth pattern of solid islands of uniform polygonal cells with minimal pleomorphism | *Insular<br>growth<br>pattern<br>of solid<br>islands of<br>uniform<br>polygonal<br>cells with<br>minimal<br>pleomorphism | ||
*Retraction of peripheral tumor cells from stroma | *Retraction<br>of<br>peripheral<br>tumor<br>cells from<br> stroma | ||
* | *Angio-<br>lymphatic<br>invasion<br>is common | ||
*Granular eosinophilic cytoplasm with either diffusely scattered or peripherally clumped granules | *Granular<br>eosinophilic<br>cytoplasm<br>with either<br>diffusely<br>scattered<br>or<br>peripherally<br>clumped<br>granules | ||
*Two types of well differentiated tumors: EC cell (serotonin producing) and rarely L-cell (enteroglucagon or peptide YY producing) | *Two types<br>of well<br>differentiated<br>tumors:<br> EC cell <br>(serotonin<br> producing) <br>and rarely<br> L-cell<br> (enteroglucagon<br>or <br>peptide YY <br>producing) | ||
'''IHC''' | [[Immunohistochemistry|'''IHC''']]''':''' | ||
*Might be<br> positive for <br>'''S100''' | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px;" |Goblet cell carcinoid | | style="background: #DCDCDC; padding: 5px;" |Goblet | ||
cell | |||
carcinoid | |||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math> | | style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* '''Generally | * '''Generally asympto-<br>matic''' | ||
* 60% present with [[acute appendicitis]] symptoms | * 60% present<br>with [[acute appendicitis]] symptoms | ||
* [[Nausea and vomiting|Nausea & vomiting]] | * [[Nausea and vomiting|Nausea<br>&<br>vomiting]] | ||
* [[decreased appetite]]<br>(anorexia) | |||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Ascites]] | * [[Ascites]] | ||
* Shifting | * Shifting<br>dullness | ||
* May | * May<br>appear<br>anemic | ||
* | * | ||
| style="background: #F5F5F5; padding: 5px;" | +/- | | style="background: #F5F5F5; padding: 5px;" | +/- | ||
Line 172: | Line 190: | ||
* '''CK 20''' | * '''CK 20''' | ||
* '''CK 7''' | * '''CK 7''' | ||
* Synapthosin | * [[Synapthosin|Synap- thosin]] | ||
* pancreatic polypeptide | * pancreatic polypeptide | ||
* CEA | * [[CEA]] | ||
* CA 19-9 | * [[CA 19-9]] | ||
* CA 125 | * [[CA-125|CA -125]] | ||
| colspan="4" style="background: #F5F5F5; padding: 5px;" |Unfortunately, compared to the other carcinoid tumors of appendix, GCC is more aggressive and patients with GCC generally present at higher stages. Hence, in addition to the above mentioned general findings for appendix cancers, imaging studies should look for evidences of peritoneal involvement, bone metastasis, lymphadenopathy, and metastatic lesions in ovaries and/or prostate. | | colspan="4" style="background: #F5F5F5; padding: 5px;" |Unfortunately,<br> compared to the other carcinoid tumors of appendix,<br> GCC is more aggressive and <br>patients with GCC generally present at higher stages.<br> Hence, in addition to<br> the above mentioned <br>general findings for appendix cancers, <br>imaging studies should <br>look for evidences of peritoneal involvement,<br> bone metastasis, lymphadenopathy, <br>and metastatic lesions<br> in ovaries and/or prostate. | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
'''Gross pathology''': | '''Gross<br>pathology''': | ||
* No gross<br>tumor might<br>be present | |||
* Thickened<br>appendiceal<br>wall | |||
'''Microscopic appearance:''' | '''Microscopic<br>appearance:''' | ||
*GCC Generally spares mucosa and infiltrates muscularis propria and | *GCC Generally<br>spares mucosa<br>and<br>infiltrates<br>muscularis<br>propria<br>and<br>peri-<br>appendiceal<br> fat | ||
*Tumor cell clusters | *Tumor<br> cell clusters | ||
*Crypt-like structures | *Crypt-like<br> structures | ||
*Tubules of mucus-secreting cells distended with mucin resembling goblet cells | *Tubules of<br> mucus-secreting <br>cells distended<br> with mucin <br>resembling<br> goblet cells | ||
*Eosinophilic cytoplasm resembling carcinoid tumors | *Eosinophilic<br> cytoplasm <br>resembling<br> carcinoid <br>tumors | ||
*Pools of extracellular mucin | *Pools of <br>extracellular<br> mucin | ||
*Scattered Paneth cells in tumors with crypt like structures | *Scattered<br>Paneth cells<br>in tumors<br>with crypt<br>like<br>structures | ||
*Extensive perineural invasion | *Extensive<br>perineural<br>invasion | ||
*'''Carcinomatous growth pattern:''' | *'''Carcinomatous<br>growth<br>pattern:''' | ||
*Cribriform<br>growth<br>pattern,<br>solid<br>sheets of<br>infiltrating<br>signet ring<br>cells | |||
*Nuclear<br>pleomorphism | |||
*Increased<br>mitotic<br>activity | |||
|- | |- | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
Line 219: | Line 237: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other diagnostic studies and imaging modalities | sounography | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
diagnostic | |||
studies | |||
and | |||
imaging | |||
modalities | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo- | |||
pathology | |||
|- | |- | ||
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix Mucocele | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Appendix Mucocele | ||
| style="background: #DCDCDC; padding: 5px;" |Mucosal | | style="background: #DCDCDC; padding: 5px;" |Mucosal | ||
[[hyperplasia]] | |||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" | | | rowspan="2" style="background: #F5F5F5; padding: 5px;" | | ||
* '''Generally asympto- | * '''Generally asympto-<br>matic''' | ||
* Benign | * Benign<br>even<br>after<br>rupture | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
Line 238: | Line 268: | ||
| rowspan="4" style="background: #F5F5F5; padding: 5px;" | | | rowspan="4" style="background: #F5F5F5; padding: 5px;" | | ||
* | * | ||
* low attenuation well defined mass in RLQ near cecum | * low<br>attenuation<br> well<br> defined<br> mass in<br> RLQ<br>near<br>cecum | ||
* Inflammation is the key to distinguish between appendicitis and mucocele | * [[Inflammation]]<br> is the key to<br> distinguish<br> between<br> appendicitis<br> and<br> mucocele | ||
* Wall thickness does not distinguish between malignant and benign mucocele | * Wall<br> thickness<br>'''does not'''<br> distinguish<br> between<br> malignant <br>and <br>benign<br> mucocele | ||
* Intramural nodule is a sign of neoplastic lesions | * Intramural<br> nodule <br>is a sign of<br> neoplastic<br> lesions. <sup>4</sup> | ||
| rowspan="4" style="background: #F5F5F5; padding: 5px;" | [https://radiopaedia.org/articles/appendiceal-mucocele-2 Rounded<br>right iliac<br> fossa mass] | |||
| rowspan="4" style="background: #F5F5F5; padding: 5px;" | | *'''T1:''' The<br>signal<br> depends<br> on <br> the mucin<br> concen-<br> tration,<br> may be<br> from<br> hypointense<br> to<br> isointense | ||
* '''T1:''' | *'''T2:'''<br> Hyperintense | ||
* '''T2:''' | |||
* | * | ||
| rowspan="4" style="background: #F5F5F5; padding: 5px;" | | | rowspan="4" style="background: #F5F5F5; padding: 5px;" | | ||
* | * Histo-<br>logically<br>benign | ||
* | * Dilated<br>fluid<br>filled<br>appendix<br>in the<br>RLQ. | ||
* Thin appendiceal wall | * Thin<br>appendiceal<br>wall | ||
* A focus of | * A focus<br>of<br>hyper-<br>echogenicity | ||
* '''Since generally there is no inflammation''' | * '''Since<br> generally<br> there is<br> no [[inflammation]]''' | ||
* Surrounding fat is normal. | * Surrounding <br>fat<br> is normal. | ||
* No peri-appendiceal fluid or collection | * No peri-<br>appendiceal <br>fluid or<br>collection | ||
| rowspan="4" style="background: #F5F5F5; padding: 5px;" |N/A | | rowspan="4" style="background: #F5F5F5; padding: 5px;" |N/A | ||
| style="background: #F5F5F5; padding: 5px;" |Similar to hyperplastic colon polyp | | style="background: #F5F5F5; padding: 5px;" |Similar<br>to<br>hyperplastic<br>colon<br>polyp | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px;" |Simple or retention cyst | | style="background: #DCDCDC; padding: 5px;" |Simple | ||
or | |||
[[Mucous retention cyst|retention]] | |||
[[Mucous retention cyst|cyst]] | |||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
Line 268: | Line 301: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" |N/A | | style="background: #F5F5F5; padding: 5px;" |N/A | ||
| style="background: #F5F5F5; padding: 5px;" |Degenerative epithelial changes because of obstruction | | style="background: #F5F5F5; padding: 5px;" |Degenerative<br>epithelial<br>changes<br>because of<br>obstruction | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px;" | Mucinous | | style="background: #DCDCDC; padding: 5px;" | Mucinous cyst- | ||
adenomas | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math> | | style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* '''Generally asympto- | * '''Generally asympto-<br>matic''' | ||
* Rupture | * Rupture<br>may<br>lead<br>to<br>Pseudo-<br>myxoma<br>peritonei | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| rowspan="2" style="background: #F5F5F5; padding: 5px;" |If develop | | rowspan="2" style="background: #F5F5F5; padding: 5px;" |If develop | ||
pseudo- | [[Pseudomyxoma peritonei|pseudo-<br>myxoma<br> peritonei]]:<br> | ||
myxoma | |||
peritonei: | |||
* [[Ascites]] | * [[Ascites]] | ||
* Shifting | * [[Shifting dullness|Shifting<br>dullness]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* CEA | * [[CEA]] | ||
* CA 19-9 | * [[CA 19-9]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Histo-<br>logically<br>benign | ||
* Similar to colon adenomatous polyps or villous adnomas | * Similar<br>to<br>colon<br>adenomatous<br>polyps or<br> villous <br>adnomas | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px;" | Mucinous | | style="background: #DCDCDC; padding: 5px;" | Mucinous [[Cystadenocarcinoma staging|cystadeno-]] | ||
[[Cystadenocarcinoma staging|carcinomas]] | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
Line 304: | Line 335: | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* CEA | * [[CEA]] | ||
* CA 19-9 | * [[CA 19-9]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Glandular invasion into the stoma | * Glandular<br>invasion<br>into the<br>stoma | ||
* | * Pseudo-<br>myxoma<br>peritonei | ||
|- | |- | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain''' | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''Abdo-<br>minal<br>pain''' | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Change in girdle size | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel<br>freq-<br>uency | ||
freq- | |||
uency | |||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | '''Other''' | ! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | '''Other''' | ||
'''symptoms''' | '''symptoms''' | ||
Line 322: | Line 350: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> tender-<br>ness | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdo-<br>minal<br> tender-<br>ness | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
physical | physical<br>exami-<br>nation<br>findings | ||
exami- | |||
nation | |||
findings | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''5-HIAA<br>and/or<br>CgA''' | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |'''5-HIAA<br>and/or<br>CgA''' | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other lab findings | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra-<br>sounography<br> | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other diagnostic studies and imaging modalities | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other<br>diagnostic<br>studies<br>and<br>imaging<br>modalities<br> | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo- | ||
pathology | |||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Ovarian cancer differential diagnosis|Ovarian cancer]] | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Ovarian cancer differential diagnosis|Ovarian cancer]] | ||
Line 342: | Line 365: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki><math>\downarrow</math> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki><math>\downarrow</math> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Pelvic/ abdominal pain or pressure | * Pelvic/ [[abdominal pain]] or pressure | ||
* Vaginal bleeding/ discharge | * [[Vaginal bleeding]]/ discharge | ||
* Dyspnea | * [[Dyspnea|Dyspne]]<nowiki/>a | ||
* GI disturbance | * GI disturbance | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px;" | + | ||
Line 350: | Line 373: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Ascites]] | * [[Ascites]] | ||
* Shifting dullness | * [[Shifting dullness]] | ||
* Fever | * [[Fever]] | ||
* Pleural effusion | * [[Pleural effusion]] | ||
| style="background: #F5F5F5; padding: 5px;" | - | | style="background: #F5F5F5; padding: 5px;" | - | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* '''Depends on the underlying etiology''' | * '''Depends<br>on<br>the<br>underlying<br>etiology''' | ||
* Iron | * Iron | ||
* HCG | * [[Human chorionic gonadotropin|HCG]] | ||
* LDH | * [[Lactate dehydrogenase|LDH]] | ||
* Calcium | * [[Calcium]] | ||
* Estrogen | * [[Estrogen]] | ||
* | * Progestron | ||
* Testosterone | * [[Testosterone|Testos-<br>terone]] | ||
* AFP | * [[Alpha-fetoprotein|AFP]] | ||
* CA 125 | * [[CA-125]] | ||
* Ki 67 | * Ki 67 | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Adnexal mass | * Adnexal<br> mass | ||
* Adenexal Cyst (simple or complex) | * Adenexal <br> Cyst<br>(simple<br>or<br>complex) | ||
* Fluid accumulation | * Fluid <br>accumulation | ||
* Endometrial thickening | * Endometrial <br>thickening | ||
* | * Calcification | ||
* Pleural effusion | * Pleural <br>effusion | ||
* Peritoneal involvement | * Peritoneal<br>involvement | ||
* | * [[Lymphadenopathy|Lympha-denopathy]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Adnexal mass | * Adnexal <br> mass | ||
* Adenexal | * Adenexal <br> cyst<br>(simple<br>or<br>complex) | ||
* Except for [[Thecoma]], ovarian masses are generally hyperintense on T1 and hypo or | * Except for<br>[[Thecoma]],<br>ovarian<br>masses <br>are <br>generally hyperintense <br>on T1 and<br>hypo or<br> sointense <br> on <br>T2 imaging | ||
* Fluid accumulation | * Fluid<br>accumulation | ||
* Endometrial thickening | * Endometrial<br>thickening | ||
* | * Calcification | ||
* Pleural effusion | * Pleural <br>effusion | ||
* Peritoneal involvement | * Peritoneal <br>involvement | ||
* | * Lympha-<br>denopathy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Adnexal mass | * Adnexal <br>mass | ||
* Adenexal | * Adenexal <br> cyst<br> (simple<br> or<br> complex) | ||
* Fluid accumulation | * Fluid <br>accumulation | ||
* Increased [[Doppler ultrasound|Doppler]] flow | * Increased <br>[[Doppler ultrasound|Doppler]]<br> flow | ||
* Endometrial thickening | * Endometrial<br>thickening | ||
* | * Calcification | ||
| style="background: #F5F5F5; padding: 5px;" | N/A | | style="background: #F5F5F5; padding: 5px;" | N/A | ||
| style="background: #F5F5F5; padding: 5px;" | Depends on the tumor type. You may find the details [[Ovarian cancer differential diagnosis|here]]. | | style="background: #F5F5F5; padding: 5px;" | Depends<br>on the<br>tumor type.<br>You may<br>find the<br>details<br>[[Ovarian cancer differential diagnosis|here]]. | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Colorectal cancer]] | | colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Colorectal cancer]] | ||
Line 402: | Line 425: | ||
* [[Weight loss]] | * [[Weight loss]] | ||
* [[Fatigue]] | * [[Fatigue]] | ||
* Low caliber | * Low caliber<br>of stools | ||
* | * Nausea<br>and<br>vomiting | ||
* [[Mucus]] in | * [[Mucus]] in<br>stools | ||
* [[Rectal prolapse]] | * [[Rectal prolapse]] | ||
* Carcinoids: | * '''in Carcinoids:''' | ||
* | *''[[Weight gain|Weight<br>loss]]'' | ||
* | *''[[Weakness]]'' | ||
* | * ''[[Flushing (physiology)|Flushing]]'' | ||
* | * ''[[Wheezing]]'' | ||
* | * ''[[Shortness of breath]]'' | ||
* | * ''[[Palpitations]]'' | ||
* | *'' [[Leg edema]]'' | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |'''Colonoscopy''' | | style="background: #F5F5F5; padding: 5px;" |'''Colonoscopy''' | ||
''Adeno-'' | ''[[Adenocarcinoma|Adeno-]]'' | ||
''carcinoma'' | ''[[Adenocarcinoma|carcinoma]]'' | ||
* [[Polyp|Polyps]] | * [[Polyp|Polyps]]<br>(villous,<br>tubular,<br>tubulo-<br>villous) | ||
* [[Ulcer|Ulcerating | * [[Ulcer|Ulcerating<br>polyps]] | ||
* [[Cancerous]] | * [[Cancerous]]<br>[[lesions]] | ||
''Carcinoids'' | ''Carcinoids'' | ||
* [[Infiltration (medical)|Infiltrating]], [[Ulceration|ulcerating]] | * [[Infiltration (medical)|Infiltrating]], [[Ulceration|ulcerating]]<br>or<br>fungating<br>lesions in<br>the<br> wall of<br>colon | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | -/+([[Carcinoid Tumor|Carcinoid tumor]]<nowiki/>s) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Anemia]] | * [[Anemia]] | ||
* Positive | * Positive<br>fecal<br>occult<br>blood<br>test | ||
* High levels of [[CEA]] and [[CA 19-9]] | * High<br>levels<br>of<br>[[CEA]]<br>and<br>[[CA 19-9]] | ||
| style="background: #F5F5F5; padding: 5px;" | luminal narrowing [[ | | style="background: #F5F5F5; padding: 5px;" | | ||
[[ | *luminal<br>narrowing<br> | ||
*[[Intestinal]]<br>wall<br>thickening,<br> | |||
*[[Intussusception|Intus-<br>susception]],<br> | |||
*[[Bowel obstruction]],<br> | |||
*[[Metastases|Hepatic<br>metastases]], | |||
*Intestinal<br>perforation,<br> | |||
*[[Lymphadenopathy|Enlarged<br>lymph<br>nodes]] | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Tumor]] mass and the extension of [[tumor]] to other structures | * [[Tumor]]<br> mass<br> and <br>the<br> extension<br> of<br> [[tumor]] to<br> other<br> structures | ||
* [[liver]], [[lung]] and [[brain]] [[Metastasis]] | * [[liver]],<br>[[lung]]<br>and<br>[[brain]]<br>[[Metastasis]] | ||
| style="background: #F5F5F5; padding: 5px;" |Generally not recommended: may evaluate liver metastasis or presence of fluid in abdominal cavity, but it is neither sensitive nor specific. | | style="background: #F5F5F5; padding: 5px;" |Generally<br>not<br>recommended:<br>may<br>evaluate<br>liver metastasis<br>or presence<br>of fluid<br>in abdominal<br>cavity, but it is <br>neither <br>sensitive<br> nor<br> specific. | ||
| style="background: #F5F5F5; padding: 5px;" |PET scan, Endoscopy, Colonoscopy, | | style="background: #F5F5F5; padding: 5px;" |[[Positron emission tomography|PET<br>scan]],<br>[[Endoscopy]],<br>[[Colonoscopy]], | ||
Barium enema | [[Lower gastrointestinal series|Barium enema]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Depends on the tumor type. | * Depends<br>on the<br>tumor<br>type.<br>You will<br>find more<br>information<br>[[Colorectal cancer differential diagnosis|here]] | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Pseudomyxoma peritonei differential diagnosis|Pseudomyxoma peritonei]] | | colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Pseudomyxoma peritonei differential diagnosis|Pseudomyxoma]] | ||
[[Pseudomyxoma peritonei differential diagnosis|peritonei]] | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
Line 454: | Line 484: | ||
| style="background: #F5F5F5; padding: 5px;" |[[Ascites]] | | style="background: #F5F5F5; padding: 5px;" |[[Ascites]] | ||
Shifting dullness | [[Shifting dullness]] | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Nonspecific | ||
* Depends on the etiology of the disease | * Depends<br>on the<br>[[etiology]]<br>of the<br>disease | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Low-attenuation | * Low-<br>attenuation<br>Scalloping<br> of the<br> visceral<br> surfaces<br> differentiates<br> [[Pseudomyxoma peritonei|pseudo-<br>myxoma]] <br>from other<br> causes of<br>[[peritonitis]]. | ||
* Typically <br>does not <br>invade<br> visceral <br>organs<br> or spread<br> by [[lymphatic]]<br> or<br> hemato-<br>genous <br>routes <br>unlike<br>mucinous<br>carcino-<br>matosis | |||
* Typically does not invade visceral organs or spread by [[lymphatic]] or | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Charact-<br> erized <br>by a mass<br>which is<br>hypointense<br>on<br>T1-weighted<br>MRI<br>and<br>hyperintense<br>on<br>T2-weighted<br>[[Magnetic resonance imaging|MRI]].<br>[[Magnetic resonance imaging|MRI]] has<br> better<br>sensitivity<br>in<br>detecting<br>[[ascites]]<br>fluid <br>and<br>[[mucocele]]. | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* The echoes within | * The echoes<br>within<br>[[Pseudomyxoma peritonei|pseudo-<br>myxoma <br>peritonei]] <br>are not <br>mobile. | ||
* Echogenic septations within the gelatinous ascites. | * Echogenic<br>septations <br>within<br> the<br> gelatinous<br> ascites. | ||
* Scalloping of the [[hepatic]] and splenic margins | * Scalloping <br>of the<br> [[hepatic]] <br>and<br>splenic <br>margins | ||
| style="background: #F5F5F5; padding: 5px;" |18F-FDG [[PET scan]] | | style="background: #F5F5F5; padding: 5px;" |18F-FDG<br> [[PET scan]] | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Depending on [[WHO]]<nowiki/>classification, whether it | * Depending<br> on<br> [[WHO]]<nowiki/> <br>classification,<br> whether it is <br>low or high <br>grade<br> with <br>cellular atypia <br>or acellular mucin. <br>( DPAM, PMCA) | ||
* Gelatinous [[ascites]] in peritoneum and [[visceral]]<nowiki/>organs,usually underneath the right hemidiaphragm, liver. | * Gelatinous<br> [[ascites]] <br>in peritoneum <br>and<br> [[visceral]]<br><nowiki/>organs,<br>usually <br>underneath<br> the right<br> hemidiaphragm,<br> liver. | ||
* Omental cake | * Omental cake | ||
[[Immunohistochemistry|'''IHC''']]''':''' | |||
*CK 20 | |||
* [[CDX2]] | |||
* [[MUC2]] | |||
* MUC5AC | |||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Carcinoid syndrome]] | | colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Carcinoid syndrome]] | ||
Line 485: | Line 513: | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<math>\uparrow</math> | | style="background: #F5F5F5; padding: 5px;" |<math>\uparrow</math> | ||
| style="background: #F5F5F5; padding: 5px;" |Flushing | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Flushing]] | |||
Palpitation | * [[Palpitation]] | ||
* [[Dyspnea]] | |||
Dyspnea | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* TR | ** [[Tricuspid regurgitation|TR]][[Heart murmur|murmur]] | ||
* Wheezing | ** [[Wheeze|Wheezing]] | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |Depends on the tumor [[Neuroendocrine tumors laboratory findings|type]]: | | style="background: #F5F5F5; padding: 5px;" |Depends<br>on the<br>tumor<br>[[Neuroendocrine tumors laboratory findings|type]]: | ||
* Ki67 | * Ki67 | ||
* N-terminal pro–B-type natriuretic peptide | * N-terminal<br>pro–B-<br>type<br>natriuretic<br>peptide | ||
* [[Substance P]] | * [[Substance P]] | ||
* [[Neurotensin]] | * [[Neurotensin]] | ||
* [[Bradykinin]] | * [[Bradykinin]] | ||
* | * Human<br>chorionic<br>gonadotropin | ||
* | * Neuro-<br>peptide L | ||
* | * Pancreatic<br>polypeptide | ||
* | * | ||
| colspan="3" style="background: #F5F5F5; padding: 5px;" |Depends on the primary tumor location and type | | colspan="3" style="background: #F5F5F5; padding: 5px;" |Depends on the <br>primary tumor location and type | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Somatostatin]] [[scintigraphy]] with 111-indium-octreotide | * [[Somatostatin]]<br>[[scintigraphy]]<br>with<br>111-indium-<br>octreotide | ||
* [[Bone]] [[scintigraphy]] with 99mTc-methylene diphosphonate (99mTcMDP) | * [[Bone]]<br>[[scintigraphy]]<br>with 99mTc-<br>methylene<br> diphosphonate<br>(99mTcMDP) | ||
* | * Positron<br>emission<br>tomography<br>(PET) | ||
* 123I-MIBG scintigraphy | * 123I-MIBG<br> scintigraphy | ||
* [[Capsule endoscopy]] (CE) | * [[Capsule endoscopy]]<br>(CE) | ||
* [[Enteroscopy]] | * [[Enteroscopy]] | ||
* Angiography | * Angiography | ||
* | * MR Angiography | ||
* [[Endoscopic]] [[ultrasonography]] (EUS) | * [[Endoscopic]]<br>[[ultrasonography]] (EUS) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Salt and pepper nuclei | * Salt<br> and<br> pepper<br> nuclei | ||
* Cellular uniformity | * Cellular<br> uniformity | ||
* Central ovoid nucleus | * Central <br>ovoid<br> nucleus | ||
* Presence of ribbons, trabeculae, nesting, glands, gyriform, pseudorosettes | * Presence of <br>ribbons,<br> trabeculae, <br>nesting, <br>glands,<br> gyriform,<br> pseudorosettes | ||
* Insulinoma (Amyloid deposition) | * Insulinoma <br>(Amyloid <br>deposition) | ||
* Somatostatinom (Psammoma bodies) | * Somatostatinom <br>(Psammoma <br>bodies) | ||
* Hyaline globules | * Hyaline <br>globules | ||
[[Immunohistochemistry|'''IHC''']]''':''' | |||
* Synaptophysin <br>(almost<br> always, <br>strongly <br>and <br>diffusely<br> expressed ) | |||
* | * CGA | ||
* CD56 and PGP<br>( less <br>specific) | |||
** | * PDX1 | ||
* ISL1 | |||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Appendicitis differential diagnosis|Appendicitis]] <sup>3</sup> | | colspan="2" style="background: #DCDCDC; padding: 5px;" |[[Appendicitis differential diagnosis|Appendicitis]] <sup>3</sup> | ||
Line 538: | Line 566: | ||
| style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math> | | style="background: #F5F5F5; padding: 5px;" | <math>\uparrow</math><math>\downarrow</math> | ||
| style="background: #F5F5F5; padding: 5px;" |[[Nausea and vomiting|Nausea & | | style="background: #F5F5F5; padding: 5px;" |[[Nausea and vomiting|Nausea<br> &<br>vomiting]],<br>decreased | ||
[[appetite]] | |||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+/-</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | | style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki> | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* | * Rebound<br>tenderness | ||
* | * Abdominal<br>guarding | ||
* [[Rovsing's sign]] | * [[Rovsing's sign|Rovsing's<br>sign]] | ||
* [[Psoas sign]] | * [[Psoas sign|Psoas<br>sign]] | ||
* [[Obturator sign]] | * [[Obturator sign|Obturator<br>sign]] | ||
* TR exam | * [[Rectal examination|TR exam]]<br>might reveal<br>tenderness<br>in the<br>[[Rectovesical excavation|rectovesical<br>pouch]] | ||
* [[Tachypnea]] | * [[Tachypnea]] | ||
* Tachycardia | * Tachycardia | ||
Line 557: | Line 586: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Leukocytosis]] | * [[Leukocytosis]] | ||
* Left shift | * [[Left shift]] | ||
| style="background: #F5F5F5; padding: 5px;" | Appendiceal wall thickening /perforation | | style="background: #F5F5F5; padding: 5px;" | | ||
*Appendiceal<br> wall<br> thickening<br> /perforation | |||
*Peri-<br>appendiceal<br>[[inflammation]],<br>fluid<br>accumulation,<br> | |||
*Fat<br>stranding | |||
| style="background: #F5F5F5; padding: 5px;" |Increased fluid signal on T2 weighted sequence | | style="background: #F5F5F5; padding: 5px;" |Increased<br> fluid<br> signal <br> on T2 <br> weighted <br> sequence | ||
| style="background: #F5F5F5; padding: 5px;" |Evidences of [[inflammation]] | | style="background: #F5F5F5; padding: 5px;" |Evidences<br> of<br> [[inflammation]] | ||
* Dilated appendix | * Dilated<br> appendix | ||
* | * Peri-<br>appendiceal <br> fluid<br> collection | ||
* Distinct appendix wall layers | * Distinct <br> [[Vermiform appendix|appendix]]<br> wall<br> layers | ||
| style="background: #F5F5F5; padding: 5px;" |[[Tc-99m]] labeled anti-[[CD15]] [[antibodies]] | | style="background: #F5F5F5; padding: 5px;" |[[Tc-99m]] <br> labeled <br> anti-<br> [[CD15]]<br> [[antibodies]] | ||
| style="background: #F5F5F5; padding: 5px;" |Evidences of [[inflammation]] | | style="background: #F5F5F5; padding: 5px;" |Evidences <br> of<br> [[inflammation]] | ||
|- | |- | ||
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases | ||
Line 575: | Line 606: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Bowel | ||
frequ- | frequ- | ||
f | |||
ency | ency | ||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | '''Other''' | ! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | '''Other''' | ||
Line 593: | Line 624: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |MRI | ||
! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! colspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Utra- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other diagnostic studies and imaging modalities | sounography | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" | | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other | ||
diagnostic | |||
studies | |||
and | |||
imaging | |||
modalities | |||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histo- | |||
pathology | |||
|} | |} | ||
<small><sup>1</sup></small> | <small><sup>1</sup></small> [[Adenocarcinoma]]<nowiki/>s usually present with appendicitis, barely they might present with [[Pseudomyxoma peritonei]]; meanwhile [[pseudomyxoma peritonei]] is more prevalent in perforated [[mucocele]], goblet cell tumor or high stages of [[Adenocarcinoma|adenocarcinoma.]] | ||
<sup>2</sup> Generally appendix carcinoids are asymptomatic, they were only become symptomatic if they metastasize to the liver, or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to | <sup>2</sup> Generally [[Vermiform appendix|appendix]] [[Carcinoid Tumor|carcinoids]] are [[asymptomatic]], they were only become symptomatic if they [[Liver mass|metastasize to the liver,]] or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to appendicea[[Adenocarcinoma|l adenocarcinoma]]. Any patient with [[carcinoid syndrome]] should be evaluated for [[Carcinoid|appendix carcinoid]]<nowiki/>s. | ||
<sup>3</sup> Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer. | <sup>3</sup> Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer. | ||
<nowiki>*</nowiki>'''Abbreviations:''' RLQ: Right Lower Quadrant, AFP: Alpha | <sup>4</sup> '''[[Imaging]]''' '''is not a reliable method to''' '''distinguish between [[Cancer|neoplastic]] and''' '''[[Neoplasm|non-neoplastic]] lesions''', hence every patient should undergo [[surgery]], appendectomy and [[Histopathology|histopathologic]] evaluation of the lesion | ||
<nowiki>*</nowiki>'''Abbreviations:''' RLQ: Right Lower Quadrant, [[Alpha-fetoprotein|AFP]]: [[Alpha-fetoprotein]], [[Human chorionic gonadotropin|HCG: Human chorionic gonadotropin]], [[Lactate dehydrogenase|LDH: Lactate Dehydrogenase]], [[Carcinoembryonic antigen|CEA: Carcinoembryonic antigen]], [[CA-125|CA-125: Cancer antigen 125]], [[5-Hydroxyindoleacetic acid|5-HIAA: Urinary 5-hydroxyindoleacetic acid]] , [[Chromogranin A|CgA: Serum Chromogranin A]] ,PU: Periumbelical, TR: [[Tricuspid regurgitation]] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Surgery]] | |||
[[Category:Medicine]] | |||
[[Category:Emergency medicine]] | |||
[[Category:Oncology]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Differential diagnosis]] |
Latest revision as of 13:26, 15 July 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]
Overview
Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs.
Differentiating appendix cancer from other Diseases
- Appendix cancer must be differentiated from benign appendix lesions (mucocele, acute appendicitis), colorectal cancers, adenexal masses (ovarian tumors), and carcinoid tumors of the other organs.
- As appendix cancer manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtype.
- Carcinoid tumors must be differentiated from other diseases that cause carcinoid syndrome sign and symptoms such as palpitation, facial flushing, and diarrhea.
- In contrast, adenocarcinomas and cystadenocarcinomas must be differentiated from other diseases that cause acute appendicitis or present with pseudomyxoma peritonei, such as colorectal cancers and appendix mucoceles.
Diseases | Clinical manifestations | Para-clinical findings | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histo-
pathology | |||||||||||||
Abdo- minal pain |
Change in girdle size | Bowel
freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities | |||
Appendix cancer | Adeno- | +/- | -/+ | <math>\downarrow</math> |
|
- | - | - |
|
|
|
Positron emission tomography (PET) |
Gross pathology:
Microscopic
IHC:
| ||
Carcinoid | +/- | - | <math>\uparrow</math> |
|
- | - | + |
Ki67: |
|
Gross pathology:
Microscopic
IHC:
| |||||
Goblet
cell carcinoid |
+ | +/- | <math>\uparrow</math> |
|
+/- | + |
|
+/- |
|
Unfortunately, compared to the other carcinoid tumors of appendix, GCC is more aggressive and patients with GCC generally present at higher stages. Hence, in addition to the above mentioned general findings for appendix cancers, imaging studies should look for evidences of peritoneal involvement, bone metastasis, lymphadenopathy, and metastatic lesions in ovaries and/or prostate. |
Gross
Microscopic
| ||||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel
freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities |
Histo-
pathology | |
Appendix Mucocele | Mucosal | - | - | - |
|
- | +/- | N/A | - | N/A |
|
Rounded right iliac fossa mass
|
|
N/A | Similar to hyperplastic colon polyp |
Simple
or |
- | - | - | - | +/- | - | - | N/A | Degenerative epithelial changes because of obstruction | ||||||
Mucinous cyst-
adenomas |
+/- | +/- | <math>\uparrow</math><math>\downarrow</math> |
|
+/- | +/- | If develop | - |
| ||||||
Mucinous cystadeno- | +/- | +/- | <math>\uparrow</math><math>\downarrow</math> | +/- | +/- | - | - |
| |||||||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel freq- uency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra- sounography |
Other diagnostic studies and imaging modalities |
Histo-
pathology | |
Ovarian cancer | +/- | +/- | +/-<math>\downarrow</math> |
|
+ | +/- | - |
|
|
|
N/A | Depends on the tumor type. You may find the details here. | |||
Colorectal cancer | +/- | +/- | <math>\uparrow</math><math>\downarrow</math> |
|
+ | +/- | Colonoscopy
Carcinoids
|
-/+(Carcinoid tumors) |
|
Generally not recommended: may evaluate liver metastasis or presence of fluid in abdominal cavity, but it is neither sensitive nor specific. |
PET scan, Endoscopy, Colonoscopy, |
| |||
Pseudomyxoma | + | + | <math>\uparrow</math><math>\downarrow</math> | Bloating | - | + | Ascites | - |
|
|
Charact- |
|
18F-FDG PET scan |
IHC: | |
Carcinoid syndrome | -/+ | - | <math>\uparrow</math> | - | - | + | Depends on the tumor type:
|
Depends on the primary tumor location and type |
|
IHC:
| |||||
Appendicitis 3 | PU, RLQ |
- | <math>\uparrow</math><math>\downarrow</math> | Nausea & vomiting, decreased |
+/- | + |
|
- |
|
Increased fluid signal on T2 weighted sequence |
Evidences of inflammation
|
Tc-99m labeled anti- CD15 antibodies |
Evidences of inflammation | ||
Diseases | Abdo- minal pain |
Change in girdle size | Bowel
frequ- f ency |
Other
symptoms |
Abdo- minal mass |
Abdo- minal tender- ness |
Other
physical exami- nation findings |
5-HIAA and/or CgA |
Other lab findings | CT scan | MRI | Utra-
sounography |
Other
diagnostic studies and imaging modalities |
Histo-
pathology |
1 Adenocarcinomas usually present with appendicitis, barely they might present with Pseudomyxoma peritonei; meanwhile pseudomyxoma peritonei is more prevalent in perforated mucocele, goblet cell tumor or high stages of adenocarcinoma.
2 Generally appendix carcinoids are asymptomatic, they were only become symptomatic if they metastasize to the liver, or in rare cases make an obstruction and present with appendicitis which is quit uncommon in appendiceal carcinoids compared to appendiceal adenocarcinoma. Any patient with carcinoid syndrome should be evaluated for appendix carcinoids.
3 Every patient with appendicitis should be evaluated for appendix cancer, 0.5 in 100 appendicitis cases are because of appendix cancer.
4 Imaging is not a reliable method to distinguish between neoplastic and non-neoplastic lesions, hence every patient should undergo surgery, appendectomy and histopathologic evaluation of the lesion
*Abbreviations: RLQ: Right Lower Quadrant, AFP: Alpha-fetoprotein, HCG: Human chorionic gonadotropin, LDH: Lactate Dehydrogenase, CEA: Carcinoembryonic antigen, CA-125: Cancer antigen 125, 5-HIAA: Urinary 5-hydroxyindoleacetic acid , CgA: Serum Chromogranin A ,PU: Periumbelical, TR: Tricuspid regurgitation